CIK 0001526119 · Non-accelerated filer<br>Smaller reporting company
Verastem, Inc.
Sign in to watch- Ticker
- VSTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- operating
- EIN
- 273269467
- Phone
- (781) 292-4200
- Business address
- 117 KENDRICK STREET, SUITE 500, NEEDHAM, MA, 02494
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $386,390
- in 4 filings, $386K under 10b5-1 plans
Net −$386,390. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-09-28 | Kauffman Michael Director | Grant or award | +4,000 | 8,000 | ||
| 2018-09-28 | Stuglik Brian M Director | Purchase | +300 | $7.31 | $2K | 300 |
| 2018-09-28 | Stuglik Brian M Director | Purchase | +100 | $7.30 | $730 | 400 |
| 2018-09-28 | Stuglik Brian M Director | Purchase | +600 | $7.30 | $4K | 1,000 |
| 2018-09-27 | Forrester Robert President and CEO | Purchase | +500 | $7.00 | $4K | 209,234 |
| 2018-09-27 | Forrester Robert President and CEO | Purchase | +10,000 | $7.00 | $70K | 219,234 |
| 2018-09-27 | Paterson Dan Chief Operating Officer | Purchase | +800 | $7.01 | $6K | 19,086 |
| 2018-09-27 | Paterson Dan Chief Operating Officer | Purchase | +1,200 | $7.04 | $8K | 20,286 |
| 2018-09-24 | Paterson Dan Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +30,000 | 30,000 | ||
| 2018-09-24 | Forrester Robert President and CEO | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2018-09-24 | Le NgocDiep T. MD, PhD Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2018-09-24 | Le NgocDiep T. MD, PhD Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +70,000 | 70,000 | ||
| 2018-09-24 | Bloom Steven H. Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +28,000 | 28,000 | ||
| 2018-08-28 | Gagnon Robert E. Chief Financial Officer | Grant or award | +50,000 | 51,000 | ||
| 2018-08-28 | Gagnon Robert E. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2018-06-08 | Lobacki Joseph M Executive VP & CCO | Purchase | +7,700 | $5.79 | $45K | 7,700 |
| 2018-06-08 | Bloom Steven H. Chief Strategy Officer | Purchase | +3,000 | $5.98 | $18K | 3,500 |
| 2018-04-06 | Paterson Dan Chief Operating Officer | Grant or award · Stock Option (Right to Buy) | +15,000 | 15,000 | ||
| 2018-04-06 | Le NgocDiep T. MD, PhD Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2018-04-06 | Bloom Steven H. Chief Strategy Officer | Grant or award · Stock Option (Right to Buy) | +14,000 | 14,000 |
Page 20 of 23 · 448 trades